Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma

Published:2021-02-15 Issue:3 Volume:39 Page:235-239
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Robinson Hannah¹,Green Michelle²,Radkar Gauri³,Ready Neal²,Strickler John²

Affiliation:

1. Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA

2. Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA

3. Virginia Oncology Associates, Norfolk, Virginia, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1884695

Reference22 articles.

1. The emerging clinical relevance of genomics in cancer medicine

2. Implementing Genome-Driven Oncology

3. Sinonasal Undifferentiated Carcinoma

4.

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

5. Incidence and Survival Patterns of Sinonasal Undifferentiated Carcinoma in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta‐analysis of multi‐modality therapies in sinonasal undifferentiated carcinoma—A timely update;Clinical Otolaryngology;2023-10-20

2. Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation;Frontiers in Oncology;2022-09-06

3. Induction chemotherapy with docetaxel and doxorubicin followed by proton beam radiation therapy for platinum-resistant unresectable sinonasal undifferentiated carcinoma;Head and Neck Tumors (HNT);2021-11-12

4. Surgical Management of Sinonasal Cancers: A Comprehensive Review;Cancers;2021-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3